Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults
Condition(s) studied
Investigational drug(s) / intervention(s)
ProNephro AKI (NGAL): ProNephro AKI™ (NGAL) is an immunoassay for the in vitro quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine.
Study summary
The purpose of this research is to collect blood and urine from adult patients admitted to an intensive care unit. This is to assess the performance of the ProNephro AKI (NGAL) assay (lab test) as an aid to identify patients at risk for acute kidney injury.
Eligibility
Primary outcome measure(s)
- Cut off Establishment — 24hrs after ICU admission
The primary objective is to establish the cut-off value for the ProNephro AKI (NGAL) in critically ill adult patients (age 22 and older) admitted to ICU when used as an aid in risk assessment of the development of moderate to severe acute kidney injury (KDIGO stage 2/3) within 48-72 hrs. after admission.
Trial sites (12)
| Facility | City | Region | Status |
|---|---|---|---|
| The University of Alabama | Birmingham | Alabama | |
| UC Davis | Sacramento | California | |
| Yale University | New Haven | Connecticut | |
| University of Chicago | Chicago | Illinois | |
| Johns Hopkins University | Baltimore | Maryland | |
| Massachusetts General Hospital | Boston | Massachusetts | |
| University of Michigan | Ann Arbor | Michigan | |
| University of New Mexico | Albuquerque | New Mexico | |
| Columbia University | New York | New York | |
| Wake Forest University | Winston-Salem | North Carolina | |
| Cleveland Clinic | Cleveland | Ohio | |
| Medical University of South Carolina | Charleston | South Carolina |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06652100 on ClinicalTrials.gov ↗ ← All trials in Mexico